Annual Total Long Term Liabilities
$4.83 M
+$789.70 K+19.57%
December 31, 2023
Summary
- As of February 7, 2025, VNRX annual total long term liabilities is $4.83 million, with the most recent change of +$789.70 thousand (+19.57%) on December 31, 2023.
- During the last 3 years, VNRX annual total long term liabilities has risen by +$1.21 million (+33.29%).
- VNRX annual total long term liabilities is now at all-time high.
Performance
VNRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$5.04 M
+$51.10 K+1.02%
September 30, 2024
Summary
- As of February 7, 2025, VNRX quarterly total long term liabilities is $5.04 million, with the most recent change of +$51.10 thousand (+1.02%) on September 30, 2024.
- Over the past year, VNRX quarterly long term liabilities has increased by +$215.50 thousand (+4.47%).
- VNRX quarterly long term liabilities is now at all-time high.
Performance
VNRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
VNRX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.6% | +4.5% |
| 3 y3 years | +33.3% | +69.7% |
| 5 y5 years | +60.0% | +79.5% |
VNRX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +48.4% | at high | +72.8% |
| 5 y | 5-year | at high | +49.3% | at high | +79.5% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
VolitionRx Limited Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.04 M(+1.0%) |
| Jun 2024 | - | $4.99 M(+9.4%) |
| Mar 2024 | - | $4.56 M(-5.5%) |
| Dec 2023 | $4.83 M(+19.6%) | $4.83 M(+49.0%) |
| Sep 2023 | - | $3.24 M(-11.0%) |
| Jun 2023 | - | $3.64 M(-3.9%) |
| Mar 2023 | - | $3.79 M(-6.2%) |
| Dec 2022 | $4.04 M(+24.1%) | $4.04 M(+14.5%) |
| Sep 2022 | - | $3.52 M(+20.8%) |
| Jun 2022 | - | $2.92 M(-13.2%) |
| Mar 2022 | - | $3.36 M(+3.3%) |
| Dec 2021 | $3.25 M(-10.2%) | $3.25 M(+9.5%) |
| Sep 2021 | - | $2.97 M(-7.6%) |
| Jun 2021 | - | $3.22 M(-3.9%) |
| Mar 2021 | - | $3.35 M(-7.6%) |
| Dec 2020 | $3.62 M(+12.0%) | $3.62 M(+28.9%) |
| Sep 2020 | - | $2.81 M(-2.3%) |
| Jun 2020 | - | $2.88 M(-5.9%) |
| Mar 2020 | - | $3.06 M(-5.5%) |
| Dec 2019 | $3.23 M(+7.2%) | $3.23 M(+18.4%) |
| Sep 2019 | - | $2.73 M(-9.0%) |
| Jun 2019 | - | $3.00 M(+5.1%) |
| Mar 2019 | - | $2.85 M(-5.4%) |
| Dec 2018 | $3.02 M(+26.9%) | $3.02 M(+2.8%) |
| Sep 2018 | - | $2.93 M(+1.0%) |
| Jun 2018 | - | $2.90 M(+23.3%) |
| Mar 2018 | - | $2.35 M(-0.9%) |
| Dec 2017 | $2.38 M(+55.9%) | $2.38 M(+11.4%) |
| Sep 2017 | - | $2.13 M(-0.5%) |
| Jun 2017 | - | $2.15 M(+21.1%) |
| Mar 2017 | - | $1.77 M(+16.2%) |
| Dec 2016 | $1.52 M | $1.52 M(+231.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $459.80 K(-3.6%) |
| Jun 2016 | - | $476.80 K(-13.1%) |
| Mar 2016 | - | $548.90 K(+0.2%) |
| Dec 2015 | $547.90 K(+55.7%) | $547.90 K(-13.7%) |
| Sep 2015 | - | $634.60 K(-1.9%) |
| Jun 2015 | - | $647.00 K(+129.8%) |
| Mar 2015 | - | $281.50 K(-20.0%) |
| Dec 2014 | $351.80 K(-18.7%) | $351.80 K(-4.2%) |
| Sep 2014 | - | $367.10 K(-14.4%) |
| Jun 2014 | - | $429.00 K(-0.8%) |
| Mar 2014 | - | $432.40 K(-0.1%) |
| Dec 2013 | $432.80 K(-31.9%) | $432.80 K(-66.1%) |
| Sep 2013 | - | $1.28 M(+11.8%) |
| Jun 2013 | - | $1.14 M(+85.1%) |
| Mar 2013 | - | $616.00 K(-3.0%) |
| Dec 2012 | $635.20 K(+2.1%) | $635.20 K(+2.8%) |
| Sep 2012 | - | $617.90 K(+2.2%) |
| Jun 2012 | - | $604.50 K(-5.8%) |
| Mar 2012 | - | $642.00 K(>+9900.0%) |
| Dec 2011 | $621.90 K(>+9900.0%) | - |
| Aug 2011 | - | $0.00(0.0%) |
| Aug 2011 | $0.00(0.0%) | - |
| May 2011 | - | $0.00(0.0%) |
| Feb 2011 | - | $0.00(0.0%) |
| Nov 2010 | - | $0.00(0.0%) |
| Aug 2010 | $0.00(0.0%) | $0.00(0.0%) |
| May 2010 | - | $0.00(0.0%) |
| Feb 2010 | - | $0.00(0.0%) |
| Nov 2009 | - | $0.00(0.0%) |
| Aug 2009 | $0.00 | $0.00(0.0%) |
| May 2009 | - | $0.00(0.0%) |
| Feb 2009 | - | $0.00 |
FAQ
- What is VolitionRx Limited annual total long term liabilities?
- What is the all time high annual total long term liabilities for VolitionRx Limited?
- What is VolitionRx Limited annual total long term liabilities year-on-year change?
- What is VolitionRx Limited quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for VolitionRx Limited?
- What is VolitionRx Limited quarterly long term liabilities year-on-year change?
What is VolitionRx Limited annual total long term liabilities?
The current annual total long term liabilities of VNRX is $4.83 M
What is the all time high annual total long term liabilities for VolitionRx Limited?
VolitionRx Limited all-time high annual total long term liabilities is $4.83 M
What is VolitionRx Limited annual total long term liabilities year-on-year change?
Over the past year, VNRX annual total long term liabilities has changed by +$789.70 K (+19.57%)
What is VolitionRx Limited quarterly total long term liabilities?
The current quarterly long term liabilities of VNRX is $5.04 M
What is the all time high quarterly long term liabilities for VolitionRx Limited?
VolitionRx Limited all-time high quarterly total long term liabilities is $5.04 M
What is VolitionRx Limited quarterly long term liabilities year-on-year change?
Over the past year, VNRX quarterly total long term liabilities has changed by +$215.50 K (+4.47%)